Article ; Online: In severe eosinophilic asthma controlled with benralizumab, tapering high-dose ICS reduced dose while maintaining control.
2024 Volume 177, Issue 4, Page(s) JC43
Abstract: Source citation: Jackson DJ, Heaney LG, Humbert M, et al; SHAMAL Investigators. ...
Abstract | Source citation: Jackson DJ, Heaney LG, Humbert M, et al; SHAMAL Investigators. |
---|---|
MeSH term(s) | Humans ; Anti-Asthmatic Agents/therapeutic use ; Disease Progression ; Asthma/drug therapy ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/adverse effects ; Adrenal Cortex Hormones/therapeutic use |
Chemical Substances | Anti-Asthmatic Agents ; benralizumab (71492GE1FX) ; Antibodies, Monoclonal, Humanized ; Adrenal Cortex Hormones |
Language | English |
Publishing date | 2024-04-02 |
Publishing country | United States |
Document type | Randomized Controlled Trial ; Multicenter Study ; Journal Article |
ZDB-ID | 336-0 |
ISSN | 1539-3704 ; 0003-4819 |
ISSN (online) | 1539-3704 |
ISSN | 0003-4819 |
DOI | 10.7326/J24-0014 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ua VI Zs.178/2: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.